Molecule Structure

Scientific Name

Duvelisib

Description of the Drug

Duvelisib is an inhibitor of phosphatidylinositol 3-kinase delta and gamma used to treat relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB11952

Brand Name(s)

Copiktra

Company Owner(s)

Secura Bio Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
PI3-kinase p110-gamma subunit SINGLE PROTEIN INHIBITOR CHEMBL3267
PI3-kinase p110-delta subunit SINGLE PROTEIN INHIBITOR CHEMBL3130

Unichem Links

SureChEMBL SCHEMBL20580104 SCHEMBL153543 SCHEMBL18343557
DrugBank DB11952
PubChem: Thomson Pharma 111324357
PubChem 50905713
LINCS LSM-42769
BindingDB 50193013
EPA CompTox Dashboard DTXSID80152697
DrugCentral 5296
ChemicalBook CB32645143
Guide to Pharmacology 7795
GSRS 3f5d6b58-b789-4be2-94a0-184e5cd275b7
rxnorm DUVELISIB COPIKTRA
ChEBI 131169
ZINC ZINC000088346058